HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gelfand, M. J. Articles by Golsch, G. J. Search for Related Content PubMed PubMed Citation Articles by Gelfand, M. J. Articles by Golsch, G. J.

Iodine-123-MIBG SPECT Versus Planar Imaging in Children with Neural Crest Tumors

Department of Radiology, Children's Hospital Medical Center and E. L. Saenger Radioisotope Laboratory, Department of Radiology, University of Cincinnati, Cincinnati, Ohio

Correspondence: For correspondence or reprints contact: Michael J. Gelfand, MD, Department of Radiology, Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229.

ABSTRACT

Iodine-123-metaiodobenzylguanidine (MIBG) SPECT was compared with ¹²³I-MIBG planar imaging in 35 studies of 25 children with neural crest tumors. Methods: Iodine-123-MIBG (0.070–0.140 mCi/kg intravenously) was followed at 24 hr by wholebody planar imaging and triple-detector, high-resolution thoracoabdominal SPECT. At 48 hr, thoracoabdominal planar imaging was performed whenever a high-tissue background or gut activity interfered with the interpretation of the 24-hr planar images. SPECT views included a cine loop presentation of multiple volume-rendered projections. Two reviewers enumerated the number of abnormal sites on the planar and SPECT studies and rated the certainty of interpretation for each study on a scale from 0.1 (low certainty) to 1.0 (high). Results: Abnormal uptake was noted on planar or SPECT imaging in 13 studies (seven patients). The average number of abnormal sites detected per study for all 35 studies was 2.7 for planar imaging and 2.9 for SPECT (p = not significant) (and 7.2 and 8.4 for planar and SPECT, respectively, for the 13 abnormal studies). The certainty ratings for all 35 studies were 0.74 for planar studies, 0.82 for SPECT (p = 0.05, chi-square, compared with planar) and 0.86 for planar and SPECT combined (p = 0.01 compared with planar alone). On volume-rendered images, gut activity was seen as diffuse and/or linear intraluminal activity. Conclusion: When ¹²³I-MIBG SPECT is used, the number of lesions detected is not increased, but there is a significant improvement in the certainty of interpretation over planar imaging.

Key Words: iodine-123-metaiodobenzylguanidine • neuroblastoma • SPECT

This article has been cited by other articles:

				C. K. McGarvey, K. Applegate, N. D. Lee, and D. K. Sokol False-Positive Metaiodobenzylguanidine Scan for Neuroblastoma in a Child With Opsoclonus-Myoclonus Syndrome Treated With Adrenocorticotropic Hormone (ACTH) J Child Neurol, July 1, 2006; 21(7): 606 - 610. [Abstract] [PDF]

				B. H. Kushner Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies J. Nucl. Med., July 1, 2004; 45(7): 1172 - 1188. [Abstract] [Full Text] [PDF]

				I. Ilias and K. Pacak Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 479 - 491. [Full Text] [PDF]

				C. Okuyama, Y. Ushijima, T. Kubota, T. Yoshida, T. Nakai, K. Kobayashi, and T. Nishimura 123I-Metaiodobenzylguanidine Uptake in the Nape of the Neck of Children: Likely Visualization of Brown Adipose Tissue J. Nucl. Med., September 1, 2003; 44(9): 1421 - 1425. [Abstract] [Full Text] [PDF]

				B. H. Kushner, S. D.J. Yeh, K. Kramer, S. M. Larson, and N.-K. V. Cheung Impact of Metaiodobenzylguanidine Scintigraphy on Assessing Response of High-Risk Neuroblastoma to Dose-Intensive Induction Chemotherapy J. Clin. Oncol., March 15, 2003; 21(6): 1082 - 1086. [Abstract] [Full Text] [PDF]